Design and preclinical evaluation of a universal SARS-CoV-2 mRNA vaccine
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1126392
Abstract: Because of the rapid mutations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an effective vaccine against SARS-CoV-2 variants is needed to prevent coronavirus disease 2019 (COVID-19). T cells, in addition to neutralizing antibodies, are… read more here.
Keywords: cell; protection; design preclinical; universal sars ... See more keywords